Valifye logoValifye

Forensic Comparison Engine · 2026

Valifye vs. CB Insights

CB Insights charges $15,000+ annually for macro market reports written for VCs, not early-stage founders. Valifye delivers founder-grade forensic audits — local tax burden, real labor rate COGS, and 90-day cash survival models — for $49. CB Insights confirms a market exists. Valifye tells you if you can actually survive in it.

3 Fatal Flaws Detected4 Feature Gaps3 Indexed Questions
The Incumbent Outputgeneric-llm
“The TAM for this sector is $5B. You should focus on social media marketing.”
Source: training data, < 2023No citations
The Valifye Auditvalifye.sys / forensic.v3
LOCAL FRICTION:14-Month Permitting Backlog in Target County
90-DAY BURN:$42,500 (Based on local labor rates)
STATUS:[ FATAL FLAW DETECTED ]
Source: street-level signals · liveAudit lock 0x7F · verified

The Interrogation

Fatal flaws Valifye uncovered.

Each flaw is a single, citable reason the incumbent fails for the specific operator profile Valifye audits for.

Flaw

VC-Grade Intelligence, Founder-Grade Irrelevance

CB Insights is engineered for institutional investors doing portfolio analysis — its output is macro sector reports, funding round data, and M&A signals. A pre-revenue founder trying to validate a B2B SaaS idea in a specific US metro gets industry abstraction, not the unit economics or survival math they actually need to make a go/no-go decision.

Flaw

Zero Operational Cost Modeling

CB Insights does not model 90-day cash burn, labor rate benchmarks, or SaaS COGS for specific business configurations. Founders who rely on it know what the 'market size' is but have no grounded view of whether their specific cost structure can survive long enough to reach it.

Flaw

Pricing Locks Out the Founders Who Need It Most

At $15,000+ per year, CB Insights is inaccessible to early-stage founders bootstrapping or on pre-seed capital. This creates a dangerous intelligence gap: the founders making the highest-stakes, irreversible decisions (quitting jobs, signing leases, raising friends-and-family rounds) are the ones with the least validated data.

The Forensic Matrix

Where the audit diverges.

FeatureCB InsightsValifye
90-Day Cash Flow Survival Modeling (Founder-Specific)Valifye models actual 90-day burn based on the founder's specific business type, local labor rates, and SaaS infrastructure costs. CB Insights provides market-level data with no operational cost modeling — a founder still needs to build their own P&L from scratch after paying $15,000.
No
Yes
Local US Regulatory Friction AnalysisValifye surfaces county-level permitting backlogs and state-specific tax and compliance exposure. CB Insights is a macro intelligence platform — it does not flag that your target market has a 14-month liquor license backlog or that your entity structure triggers a specific state franchise tax.
No
Yes
GTM Execution Roadmap (90-Day Tactical)Valifye generates a channel-specific, sequenced GTM roadmap calibrated to the founder's ICP, geography, and stage. CB Insights provides competitive landscape and funding data — the tactical execution layer is entirely absent, leaving founders to self-architect their own go-to-market from generic market intelligence.
No
Yes
Pivot Playbooks for Failed ValidationValifye generates structured Pivot Playbooks with recalculated unit economics when primary validation fails. CB Insights has no failure-state protocol — it produces reports assuming the market is already worth entering, with no framework for what to do when your specific configuration doesn't pencil out.
No
Yes

The Kill Shot

CB Insights is a Bloomberg terminal for VCs — powerful, prestigious, and completely misaligned with what a founder needs at the most dangerous moment of their company's life. Valifye provides the forensic survival intelligence that CB Insights was never designed to deliver, at 0.3% of the annual cost.

Pricing Gap

$15,000+/yr (macro VC-grade reports) vs $49 flat (founder-grade forensic audit)

Stop guessing. Run a Valifye forensic audit on your exact market in 48 hours.